For many investors in 2019, the name of the game is speculation.
Of course, it has also been a huge year for initial public offerings. As always, IPOs and speculation often go hand in hand.
As we look ahead to the second half of 2019, IPOs will be one of the biggest focuses, and we expect the biotech IPOs to take center stage.